Why Tilray Bears Could Go Up In Smoke If History Repeats
Tilray Inc (NASDAQ: TLRY) gapped up over 5% higher on Wednesday before dropping down to fill the area and bouncing.
Analyst Says MedMen’s Momentum Changing, Tilray’s Stake Won’t Double Its Value But Will Hold Premium
MedMen Enterprises Inc. (OTCQX: MMNFF) revealed Tuesday that it has secured $100 million in financing via a private sale of its units in a deal led by Serruya Private Equity.
MedMen Announces $100M Equity Investment On Heels Of Tilray Buying Its Convertible Debt, Deal Led By Serruya Private Equity
Cannabis retailer MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has secured $100 million in financing through a private placement of its units.
Why Tilray Shares Are Trading Higher Today
Tilray Inc (NASDAQ: TLRY) is trading higher Wednesday after the company announced that it acquired the majority of the outstanding senior secured convertible notes of MedMen Enterprises Inc (OTCQX: MMNFF)
Cantor Fitzgerald Says Tilray’s Stake In MedMen One Of The Steps In US Journey, Could Be Getting Close To Altria
Canadian cannabis giant Tilray, Inc. NASDAQ: TLRY) announced Tuesday it has acquired the majority of the outstanding senior secured convertible notes of</
Cantor Fitzgerald Upgrades MedMen Enterprises to Neutral, Announces $0.3 Price Target
Cantor Fitzgerald analyst Pablo Zuanic upgrades MedMen Enterprises (OTC:MMNFF) from Underweight to Neutral and announces $0.3 price target.
Tilray Acquires Majority Position In Amended MedMen Convertible Notes, Accelerating Path Into US Cannabis Market If Federal Legalization Occurs
Tilray, Inc. (NASDAQ: TLRY), and MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF), announced on Tuesday Tilray has acquired the majority of MedMen’s outstanding senior secured convertible notes
Why Tilray’s Stock Is Trading Higher After Hours
Tilray Inc (NASDAQ: TLRY) shares are trading higher following news the company purchased a majority position in amended Medmen Enterprises Inc (OTC: MMNFF) convertible notes for about $165.8 million.
Tilray Reports Purchase Of Majority Position In MedMen Convertible Notes For ~$165.8M
Investment Provides Tilray a Potential Accelerated Path into U.S. Cannabis Market Upon Federal Legalization
Amendment and Extension of Convertible Notes Enables MedMen to Reshape Balance Sheet and Further Accelerate its